Healthy Skepticism Library item: 3623

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

MaLAM letter follow up—Janssen
1988 Feb;

Abstract:

Janssen has provided 14 studies to support its claims about flunarizine but these studies have serious methodologic problems.

Keywords:
*analysis/flunarizine/Janssen/company responses/quality of information/neurologic drugs/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: NEUROLOGIC DISEASES